M&A Deal Summary |
|
|---|---|
| Date | 2018-10-22 |
| Target | SpineThera |
| Sector | Life Science |
| Buyer(s) | Purdue Pharma |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Lake Street Capital Markets (Financial) Fox Rothschild (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1982 |
| Sector | Life Science |
Purdue Pharma LP is a privately-held pharmaceutical companies known for pioneering research in chronic pain.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2018 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-09-08 |
VM Pharma - TrkA Program
United States VM Pharma - TrkA Program is a provider of important signaling proteins known as tyrosine receptor kinases. |
Buy | - |